Anupam Rasayan is Preparing to Acquire 43% Stake in Bliss GVS Pharma for Around ₹1,369 Crore
Anupam Rasayan India the Gujarat based Specialty chemicals maker is all set to acquire 43.3 % stake in pharmaceutical formulations company Bliss GVS Pharma Ltd. According to reports Anupam Rasayan has already signed an agreement...
Bristol Myers Squibb Secures Dual Regulatory Wins for Opdivo® in Classical Hodgkin Lymphoma
Bristol Myers Squibb (NYSE: BMY) announced that Opdivo® (nivolumab) has received approval for two new classical Hodgkin Lymphoma (cHL) indications in the U.S. and...
Lupin Secures ANDA Approval, Set to Enter the Chinese Market
Indian global pharma giant on 22 May, though a press release has announced that the company has received the China's National Medical Products Administration’s (NMPA) approval of Abbreviated New Drug Application (ANDA) for its Oseltamivir...
Alembic Receives USFDA Approval for Levothyroxine Sodium Tablets
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
Commitment Towards Precise Diagnostic Services: Metropolis Healthcare Launches New Greenfield Laboratoryin Panjab
On 22nd May 2026, the Metropolis Healthcare, one of Indias leading diagnostics chain launches their new “Greenfield Laboratory” in Panjab’s Amritsar. The inauguration was graced by Dr. Anumeet Singh Grover, renowned gastroenterologist along with other renowned medical professionals across the country and...
FDA Approves Datroway for Metastatic Triple-Negative Breast Cancer
AstraZeneca and Daiichi Sankyo announced that the US Food and Drug Administration (FDA) has approved Datroway(datopotamab deruxtecan) for adult patients with unresectable or metastatic triple-negative breast cancer (TNBC)...